Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by White Mark K., Director. Officer active across 1 company, notably Annovis Bio, Inc.. Cumulatively, 4 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €119k. History available since 12 October 2021. The latest transaction was disclosed on 20 November 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Mark K. White serves as a Board Member at Annovis Bio, Inc. He contributes to corporate governance and strategic decision-making within the board. His role involves assessing the company's performance and overseeing initiatives aimed at enhancing operational efficiency. Mark is committed to promoting transparency and accountability in the company's operations.